1. Home
  2. PODD vs PHG Comparison

PODD vs PHG Comparison

Compare PODD & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$304.01

Market Cap

22.1B

Sector

Health Care

ML Signal

HOLD

Logo Koninklijke Philips N.V. NY Registry Shares

PHG

Koninklijke Philips N.V. NY Registry Shares

HOLD

Current Price

$27.07

Market Cap

26.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PODD
PHG
Founded
2000
1891
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.1B
26.8B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
PODD
PHG
Price
$304.01
$27.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
1
Target Price
$359.00
N/A
AVG Volume (30 Days)
765.6K
651.5K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
3.04%
EPS Growth
N/A
N/A
EPS
3.45
0.21
Revenue
$2,521,800,000.00
$20,861,199,111.00
Revenue This Year
$32.55
$0.72
Revenue Next Year
$20.39
$3.11
P/E Ratio
$88.24
$132.98
Revenue Growth
27.11
N/A
52 Week Low
$230.05
$21.48
52 Week High
$354.88
$29.54

Technical Indicators

Market Signals
Indicator
PODD
PHG
Relative Strength Index (RSI) 40.94 42.53
Support Level $303.20 $26.30
Resistance Level $317.34 $28.32
Average True Range (ATR) 13.12 0.36
MACD -2.82 -0.09
Stochastic Oscillator 3.14 32.53

Price Performance

Historical Comparison
PODD
PHG

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About PHG Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

Share on Social Networks: